Abcam PLC
LSE:ABC
Intrinsic Value
Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of ABC.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Abcam PLC's business.
What risks and challenges
does Abcam PLC face in the near future?
Summarize the latest earnings report
of Abcam PLC.
Provide P/E
for Abcam PLC and its competitors.
Balance Sheet Decomposition
Abcam PLC
Current Assets | 257.8m |
Cash & Short-Term Investments | 109.6m |
Receivables | 72.1m |
Other Current Assets | 76.1m |
Non-Current Assets | 806.9m |
Long-Term Investments | 3.3m |
PP&E | 165.7m |
Intangibles | 625.9m |
Other Non-Current Assets | 12m |
Current Liabilities | 203.8m |
Accounts Payable | 56.7m |
Short-Term Debt | 119.4m |
Other Current Liabilities | 27.7m |
Non-Current Liabilities | 133.3m |
Long-Term Debt | 96.5m |
Other Non-Current Liabilities | 36.8m |
Earnings Waterfall
Abcam PLC
Revenue
|
350.4m
GBP
|
Cost of Revenue
|
-95.7m
GBP
|
Gross Profit
|
254.7m
GBP
|
Operating Expenses
|
-224.2m
GBP
|
Operating Income
|
30.5m
GBP
|
Other Expenses
|
-23.7m
GBP
|
Net Income
|
6.8m
GBP
|
Free Cash Flow Analysis
Abcam PLC
What is Free Cash Flow?
ABC Profitability Score
Profitability Due Diligence
Abcam PLC's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Abcam PLC's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
ABC Solvency Score
Solvency Due Diligence
Abcam PLC's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Score
Abcam PLC's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ABC Price Targets Summary
Abcam PLC
According to Wall Street analysts, the average 1-year price target for ABC is 1 560.29 GBX .
Shareholder Return
ABC Price
Abcam PLC
Average Annual Return | 16.31% |
Standard Deviation of Annual Returns | 6.68% |
Max Drawdown | -40% |
Market Capitalization | 2.8B GBX |
Shares Outstanding | 228 654 500 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. The company is headquartered in Cambridge, Cambridgeshire and currently employs 1,750 full-time employees. The company went IPO on 2005-11-03. The firm is focused on identifying, developing and distributing reagents and tools which are required in the fields of life science research. The firm's product offering includes portfolio of antibodies and related protein research tools that are fundamental to its customers' research and experimental workflow. The firm's product type includes primary antibodies, secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selector, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers. The firm's products are used by researchers to study biological pathways, which is critical for scientific research, diagnostics and drug discovery. The firm serves scientists and researchers in academic institutions, research institutes and pharmaceutical, biotechnology and diagnostics companies.